This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chuang, J.-H. Articles by Heitjan, D. F. Search for Related Content PubMed PubMed Citation Articles by Chuang, J.-H. Articles by Heitjan, D. F.

Design and Analysis of Controlled Trials in Naturally Clustered Environments

Implications for Medical Informatics

Affiliation of the authors: Columbia University, New York, New York (J-HC, GH, DF); National Yang-Ming University, Taipei, Taiwan (JHC).

Correspondence and reprints: Jen-Hsiang Chuang, MD, MS, Department of Medical Informatics, Columbia University, 622 West 168th Street, Vanderbilt Clinic, 5th Floor, New York, NY 10032; e-mail: <chuangj{at}dmi.columbia.edu>.

Received for publication: 08/01/01; accepted for publication: 01/03/02.

In medical informatics research, study questions frequently involve individuals who are grouped into clusters. For example, an intervention may be aimed at a clinician (who treats a cluster of patients) with the intention of improving the health of individual patients. Correlation among individuals within a cluster can lead to incorrect estimates of the sample size required to detect an effect and inappropriate estimates of the confidence intervals and the statistical significance of the intervention effects. Contamination, which is the spread of the effect of an intervention or control treatment to the opposite group, often occurs between individuals within clusters. It leads to an attenuation of the effect of the intervention and reduced power to detect a difference. If individuals are randomized in a clinical trial (individual-randomized trial), then correlation must be taken into account in the analysis, and the sample size may need to be increased to compensate for contamination. Randomizing clusters rather than individuals (cluster-randomized trials) can eliminate contamination and may be preferred for logistical reasons. Cluster-randomized trials are generally less efficient than individual-randomized trials, so the tradeoffs must be assessed. Correlation must be taken into account in the analysis and in the sample-size calculations for cluster-randomized trials.

This article has been cited by other articles:

				I. Shcherbatykh, A. Holbrook, L. Thabane, L. Dolovich, and COMPETE III investigators Methodologic Issues in Health Informatics Trials: The Complexities of Complex Interventions J. Am. Med. Inform. Assoc., September 1, 2008; 15(5): 575 - 580. [Abstract] [Full Text] [PDF]

				B. Roudsari, R. Fowler, and A. Nathens Intracluster correlation coefficient in multicenter childhood trauma studies Inj. Prev., October 1, 2007; 13(5): 344 - 347. [Abstract] [Full Text] [PDF]

				A. X. Garg, N. K. J. Adhikari, H. McDonald, M. P. Rosas-Arellano, P. J. Devereaux, J. Beyene, J. Sam, and R. B. Haynes Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes: A Systematic Review JAMA, March 9, 2005; 293(10): 1223 - 1238. [Abstract] [Full Text] [PDF]